Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Dynamics of the type III secretion system activity of enteropathogenic Escherichia coli.

Mills E, Baruch K, Aviv G, Nitzan M, Rosenshine I.

MBio. 2013 Jul 30;4(4). pii: e00303-13. doi: 10.1128/mBio.00303-13.

2.

EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.

Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G.

MBio. 2012 Oct 2;3(5). pii: e00317-12. doi: 10.1128/mBio.00317-12. Print 2012.

3.

Transient shielding of intimin and the type III secretion system of enterohemorrhagic and enteropathogenic Escherichia coli by a group 4 capsule.

Shifrin Y, Peleg A, Ilan O, Nadler C, Kobi S, Baruch K, Yerushalmi G, Berdichevsky T, Altuvia S, Elgrably-Weiss M, Abe C, Knutton S, Sasakawa C, Ritchie JM, Waldor MK, Rosenshine I.

J Bacteriol. 2008 Jul;190(14):5063-74. doi: 10.1128/JB.00440-08. Epub 2008 May 23.

4.

Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system.

Martinez-Argudo I, Sands C, Jepson MA.

Cell Microbiol. 2007 Jun;9(6):1538-46. Epub 2007 Feb 9.

PMID:
17298392
5.

Designed coiled-coil peptides inhibit the type three secretion system of enteropathogenic Escherichia coli.

Larzábal M, Mercado EC, Vilte DA, Salazar-González H, Cataldi A, Navarro-Garcia F.

PLoS One. 2010 Feb 4;5(2):e9046. doi: 10.1371/journal.pone.0009046.

6.

Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.

Arbeloa A, Oates CV, Marchès O, Hartland EL, Frankel G.

Infect Immun. 2011 Mar;79(3):1067-76. doi: 10.1128/IAI.01003-10. Epub 2010 Dec 28.

8.

Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated.

DeVinney R, Stein M, Reinscheid D, Abe A, Ruschkowski S, Finlay BB.

Infect Immun. 1999 May;67(5):2389-98.

9.

EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems.

Vidal JE, Navarro-García F.

Cell Microbiol. 2008 Oct;10(10):1975-86. doi: 10.1111/j.1462-5822.2008.01181.x. Epub 2008 Jun 10.

PMID:
18547338
10.

Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli.

Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I.

Cell Host Microbe. 2008 Feb 14;3(2):104-13. doi: 10.1016/j.chom.2007.11.007.

11.

Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells.

Sharma R, Tesfay S, Tomson FL, Kanteti RP, Viswanathan VK, Hecht G.

Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G685-94. Epub 2005 Dec 1.

12.

Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells.

Hayward RD, Cain RJ, McGhie EJ, Phillips N, Garner MJ, Koronakis V.

Mol Microbiol. 2005 May;56(3):590-603.

13.

Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.

Gruenheid S, Sekirov I, Thomas NA, Deng W, O'Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB.

Mol Microbiol. 2004 Mar;51(5):1233-49.

14.

Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens.

Deng W, Yu HB, de Hoog CL, Stoynov N, Li Y, Foster LJ, Finlay BB.

Mol Cell Proteomics. 2012 Sep;11(9):692-709. doi: 10.1074/mcp.M111.013672. Epub 2012 Jun 1.

15.

Polymorphisms within EspA filaments of enteropathogenic and enterohemorrhagic Escherichia coli.

Neves BC, Shaw RK, Frankel G, Knutton S.

Infect Immun. 2003 Apr;71(4):2262-5.

16.

The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.

Thanabalasuriar A, Kim J, Gruenheid S.

Microbes Infect. 2013 Sep-Oct;15(10-11):738-44. doi: 10.1016/j.micinf.2013.05.001. Epub 2013 Jun 6.

PMID:
23747681
17.

Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli.

Wolff C, Nisan I, Hanski E, Frankel G, Rosenshine I.

Mol Microbiol. 1998 Apr;28(1):143-55.

18.

Role of EscU auto-cleavage in promoting type III effector translocation into host cells by enteropathogenic Escherichia coli.

Thomassin JL, He X, Thomas NA.

BMC Microbiol. 2011 Sep 20;11:205. doi: 10.1186/1471-2180-11-205.

19.

Identification and characterization of NleI, a new non-LEE-encoded effector of enteropathogenic Escherichia coli (EPEC).

Li M, Rosenshine I, Yu HB, Nadler C, Mills E, Hew CL, Leung KY.

Microbes Infect. 2006 Nov-Dec;8(14-15):2890-8. Epub 2006 Oct 16.

PMID:
17097322
20.

Supplemental Content

Support Center